We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AJP:GETTEXArtmarket.com SA Analysis

Data as of 2026-06-19 - not real-time

€2.17

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Artmarket.com is trading at €2.17, well below its 20‑day (≈2.50) and 50‑day (2.63) simple moving averages, indicating a persistent bearish price bias. The RSI of 28.7 places the stock in oversold territory, while the MACD remains bearish with its line below the signal (-0.135 vs -0.096), suggesting limited near‑term upside. Volume has been decreasing and 30‑day volatility is high at 61%, compounding liquidity concerns for a market‑cap of only €15.4 M. Fundamentally, the company shows flat revenue growth (1%), thin operating margins (6.4%), a low ROE (2%), and a high debt‑to‑equity ratio (3.14), all of which weigh against the equity’s prospects. The DCF‑derived fair value of €1.46 is well below the current price, reinforcing an overvalued assessment despite a modest price‑to‑book ratio of 0.45.
Given the extreme greed sentiment in the broader market (Fear & Greed Index 92), the stock’s technical oversold signal could invite a short‑term bounce to the nearby support at €2.12. However, the combination of weak earnings, high leverage, negative free cash flow, and low liquidity suggests that any recovery is likely limited and that the equity remains a high‑risk, value‑oriented play rather than a growth opportunity.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • RSI below 30 indicating oversold conditions
  • Price hovering near the identified support level
  • Low price‑to‑book ratio suggesting some intrinsic value

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • Bearish technical trend across multiple moving averages
  • High volatility and decreasing trading volume
  • Weak profitability and high leverage limiting upside

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • DCF fair value significantly below current market price
  • Sustained low growth and thin margins
  • Elevated debt‑to‑equity ratio and negative free cash flow

Key Metrics & Analysis

Financial Health

Revenue Growth1.00%
Profit Margin7.60%
ROE1.99%
ROA0.78%
Debt/Equity3.14
P/B Ratio0.4
Op. Cash Flow€911.0K
Free Cash Flow€-64125
Industry P/E16.7

Technical Analysis

TrendBearish
RSI28.7
Support€2.12
Resistance€2.92
MA 20€2.50
MA 50€2.63
MA 200€3.23
MACDBearish
VolumeDecreasing
Fear & Greed Index92.14

Valuation

Fair Value€1.46
GradeOvervalued
TypeValue

Risk Assessment

Beta0.80
Volatility61.45%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.